true 0001680367 0001680367 2024-03-01 2024-03-01

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K/A

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 1, 2024

 

 

Shattuck Labs, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39593   81-2575858

(State or other jurisdiction of

incorporation or organization)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification Number)

500 W. 5th Street, Suite 1200

Austin, TX 78701

(Address of principal executive offices including zip code)

(512) 900-4690

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuance to Section 12(b) of the Act:

 

Title of each class

  

Trading

Symbol(s)

  

Name of each exchange

on which registered

Common Stock, par value $0.0001 per share   STTK   The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 4, 2024, Shattuck Labs, Inc. (the “Company”) filed a Current Report on Form 8-K under Item 5.02 pursuant to which the Company announced that its Board of Directors (the “Board”) had appointed Drs. Kate Sasser and Clay Siegall to the Board (the “Original Form 8-K”). At that time, the Board had not yet appointed Drs. Sasser and Siegall to any Board committees.

In accordance with Securities and Exchange Commission rules, this amendment to the Original Form 8-K is being filed to report that effective June 11, 2024, the Board appointed Dr. Sasser to the Nominating and Corporate Governance Committee and Dr. Siegall to the Compensation Committee.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Shattuck Labs, Inc.
Date: June 11, 2024     By:  

/s/ Dr. Taylor Schreiber

     

Dr. Taylor Schreiber

Chief Executive Officer

(principal executive officer)

v3.24.1.1.u2
Document and Entity Information
Mar. 01, 2024
Cover [Abstract]  
Amendment Flag true
Entity Central Index Key 0001680367
Document Type 8-K/A
Document Period End Date Mar. 01, 2024
Entity Registrant Name Shattuck Labs, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-39593
Entity Tax Identification Number 81-2575858
Entity Address, Address Line One 500 W. 5th Street
Entity Address, Address Line Two Suite 1200
Entity Address, City or Town Austin
Entity Address, State or Province TX
Entity Address, Postal Zip Code 78701
City Area Code (512)
Local Phone Number 900-4690
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.0001 per share
Trading Symbol STTK
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
Amendment Description On March 4, 2024, Shattuck Labs, Inc. (the “Company”) filed a Current Report on Form 8-K under Item 5.02 pursuant to which the Company announced that its Board of Directors (the “Board”) had appointed Drs. Kate Sasser and Clay Siegall to the Board (the “Original Form 8-K”). At that time, the Board had not yet appointed Drs. Sasser and Siegall to any Board committees. In accordance with Securities and Exchange Commission rules, this amendment to the Original Form 8-K is being filed to report that effective June 11, 2024, the Board appointed Dr. Sasser to the Nominating and Corporate Governance Committee and Dr. Siegall to the Compensation Committee.
Shattuck Labs (NASDAQ:STTK)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Shattuck Labs Charts.
Shattuck Labs (NASDAQ:STTK)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Shattuck Labs Charts.